Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Green

Showing results (1-10 of 305) with videos related to

Pageof 31
Sort By:
Pathology|January 2, 2017
Molecular classification of breast cancer: what the pathologist needs to knowEmad A Rakha, Andrew R Green
Histopathology|September 2, 2021
Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literatureJahnavi Kalvala, Ruth M Parks, Andrew R Green, et al.
International Journal of Biological Macromolecules|February 17, 2019
<sup>1</sup>H NMR characterization of chitin tetrasaccharide in binary H<sub>2</sub>O:DMSO solution: Evidence for anomeric end-effect propagationKecheng Li, Andrew R Green, Meredith M Dinges, et al.
Virchows Archiv : an International Journal of Pathology|April 22, 2011
The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progressionLivia Quattrocchi, Andrew R Green, Stewart Martin, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2011
Detection and quantification of microRNAs in laser-microdissected formalin-fixed paraffin-embedded breast cancer tissuesSarkawt M Khoshnaw, Des G Powe, Ian O Ellis, et al.
Human Pathology|April 12, 2013
Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survivalAlex Gan, Andrew R Green, Christopher C Nolan, et al.
Breast Cancer Research and Treatment|November 23, 2022
The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion developmentAbrar I Aljohani, Michael S Toss, Andrew R Green, et al.
Histopathology|April 1, 2018
Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancerLutfi Alfarsi, Simon Johnston, Dong-Xu Liu, et al.
Advances in Therapy|April 28, 2023
Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific SurvivalJahnavi Kalvala, Ruth M Parks, Jamal Abdi, et al.
Histopathology|May 13, 2010
Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatmentsFabrício F T Barros, Desmond G Powe, Ian O Ellis, et al.
Pageof 31

Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Pathology|January 2, 2017
Molecular classification of breast cancer: what the pathologist needs to knowEmad A Rakha, Andrew R Green
Histopathology|September 2, 2021
Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literatureJahnavi Kalvala, Ruth M Parks, Andrew R Green, et al.
International Journal of Biological Macromolecules|February 17, 2019
<sup>1</sup>H NMR characterization of chitin tetrasaccharide in binary H<sub>2</sub>O:DMSO solution: Evidence for anomeric end-effect propagationKecheng Li, Andrew R Green, Meredith M Dinges, et al.
Virchows Archiv : an International Journal of Pathology|April 22, 2011
The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progressionLivia Quattrocchi, Andrew R Green, Stewart Martin, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2011
Detection and quantification of microRNAs in laser-microdissected formalin-fixed paraffin-embedded breast cancer tissuesSarkawt M Khoshnaw, Des G Powe, Ian O Ellis, et al.
Human Pathology|April 12, 2013
Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survivalAlex Gan, Andrew R Green, Christopher C Nolan, et al.
Breast Cancer Research and Treatment|November 23, 2022
The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion developmentAbrar I Aljohani, Michael S Toss, Andrew R Green, et al.
Histopathology|April 1, 2018
Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancerLutfi Alfarsi, Simon Johnston, Dong-Xu Liu, et al.
Advances in Therapy|April 28, 2023
Assessment of the Androgen Receptor in Older Women with Primary Breast Cancer: Association with a Panel of Biomarkers and Breast Cancer Specific SurvivalJahnavi Kalvala, Ruth M Parks, Jamal Abdi, et al.
Histopathology|May 13, 2010
Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatmentsFabrício F T Barros, Desmond G Powe, Ian O Ellis, et al.
Pageof 31